ISM8207

· InSilico Medicine Hong Kong Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISM8207, covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma [Phase 1]

See pricing